As of 2026-09-24, the Relative Valuation of Akebia Therapeutics Inc (AKBA) is (1.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.93 USD, the upside of Akebia Therapeutics Inc based on Relative Valuation is -303.4%.
The range of the Relative Valuation is (1.76) - (1.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 21.7x | 18.4x |
| Forward P/E multiples | 15.4x - 16.4x | 15.9x |
| Fair Price | (1.76) - (1.81) | (1.90) |
| Upside | -289.3% - -294.5% | -303.4% |
| Date | P/E |
| 2026-09-18 | -8.28 |
| 2026-09-17 | -8.10 |
| 2026-09-16 | -8.30 |
| 2026-09-15 | -8.17 |
| 2026-09-14 | -8.71 |
| 2026-09-11 | -8.61 |
| 2026-09-10 | -8.56 |
| 2026-09-09 | -8.63 |
| 2026-09-08 | -9.31 |
| 2026-09-04 | -8.81 |
| 2026-09-03 | -8.89 |
| 2026-09-02 | -8.86 |
| 2026-09-01 | -8.54 |
| 2026-08-31 | -8.31 |
| 2026-08-28 | -7.94 |
| 2026-08-27 | -8.50 |
| 2026-08-26 | -8.20 |
| 2026-08-25 | -8.67 |
| 2026-08-24 | -8.14 |
| 2026-08-21 | -8.20 |
| 2026-08-20 | -8.31 |
| 2026-08-19 | -8.01 |
| 2026-08-18 | -7.70 |
| 2026-08-17 | -7.78 |
| 2026-08-14 | -7.89 |
| 2026-08-13 | -7.86 |
| 2026-08-12 | -8.08 |
| 2026-08-11 | -7.84 |
| 2026-08-10 | -7.63 |
| 2026-08-07 | -8.23 |
| 2026-08-06 | -8.63 |
| 2026-08-05 | -11.67 |
| 2026-08-04 | -11.94 |
| 2026-08-03 | -11.85 |
| 2026-07-31 | -11.94 |
| 2026-07-30 | -12.21 |
| 2026-07-29 | -11.39 |
| 2026-07-28 | -11.48 |
| 2026-07-27 | -11.57 |
| 2026-07-24 | -11.03 |
| 2026-07-23 | -11.03 |
| 2026-07-22 | -11.39 |
| 2026-07-21 | -11.76 |
| 2026-07-20 | -11.57 |
| 2026-07-17 | -12.12 |
| 2026-07-16 | -12.66 |
| 2026-07-15 | -12.48 |
| 2026-07-14 | -12.66 |
| 2026-07-13 | -12.48 |
| 2026-07-10 | -12.66 |